Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Search
No matching results for ''
Tip: Try a valid symbol or a specific company name for relevant results
Mail
Finance Home
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
The New Investors
All Markets Summit
Give Feedback
Australia markets closed
ALL ORDS
6,877.90
-75.50
(-1.09%)
AUD/USD
0.6886
-0.0039
(-0.57%)
ASX 200
6,700.20
-63.40
(-0.94%)
OIL
111.36
-0.40
(-0.36%)
GOLD
1,819.10
-2.10
(-0.12%)
BTC-AUD
29,066.20
-1,472.79
(-4.82%)
📩 Sign up now
News that makes you smarter and richer... For free.
Get Fully Briefed with Yahoo Finance, delivered straight to your inbox.
Clarus Therapeutics Holdings, Inc. (CRXT)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.4300
+0.0202
(+4.93%)
At close: 04:00PM EDT
0.4250
-0.00
(-1.16%)
After hours:
07:59PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
Total revenue
13,957
13,957
6,369
Cost of revenue
2,720
2,720
8,687
Gross profit
11,237
11,237
-2,318
Operating expenses
Research development
3,630
3,630
2,398
Selling general and administrative
47,339
47,339
42,461
Total operating expenses
50,969
50,969
44,859
Operating income or loss
-39,732
-39,732
-47,177
Interest expense
15,895
15,895
15,394
Total other income/expenses net
15,008
15,008
66,891
Income before tax
-40,617
-40,617
4,345
Income tax expense
0
0
0
Income from continuing operations
-40,617
-40,617
4,345
Net income
-40,617
-40,617
4,345
Net income available to common shareholders
-40,205
-40,205
-10,337
Basic EPS
-
-5.72
-0.48
Diluted EPS
-
-5.72
-3.22
Basic average shares
-
7,028
21,726
Diluted average shares
-
7,028
21,726
EBITDA
-
-24,697
19,757
© 2022 Yahoo. All rights reserved.
Data disclaimer
Help
Suggestions
Privacy Dashboard
Privacy (updated)
About our ads
Terms (updated)